Biomaterial Database

[Treatment of lower respiratory tract infections with cefuroxime-axetil. Comparison with cefaclor]. 1988

R Pariente, and J Rochemaure, and D Murciano, and J M Brechot, and M Pappo

UI	MeSH Term	Description	Entries
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D012141	Respiratory Tract Infections	Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.	Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002433	Cefaclor	Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.	5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-,Ceclor,Cefaclor Anhydrous,Cefaclor Monohydrate,Keclor,Lilly 99638,S-6472,S 6472,S6472
D002444	Cefuroxime	Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.	Cephuroxime,Ketocef,Zinacef
D002506	Cephalexin	A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.	5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D002511	Cephalosporins	A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.	Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004341	Drug Evaluation	Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.	Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Pariente, and J Rochemaure, and D Murciano, and J M Brechot, and M Pappo

Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.

February 1988, Archives of internal medicine,

R Pariente, and J Rochemaure, and D Murciano, and J M Brechot, and M Pappo

Treatment of community-acquired lower respiratory tract infections with oral cefuroxime axetil.

January 1990, Clinical therapeutics,

R Pariente, and J Rochemaure, and D Murciano, and J M Brechot, and M Pappo

A comparison of cefuroxime axetil and amoxycillin in the treatment of lower respiratory tract infections.

July 1989, Journal of chemotherapy (Florence, Italy),

R Pariente, and J Rochemaure, and D Murciano, and J M Brechot, and M Pappo

A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections.

September 1985, The Journal of antimicrobial chemotherapy,

R Pariente, and J Rochemaure, and D Murciano, and J M Brechot, and M Pappo

A comparison of the safety and efficacy of cefuroxime axetil and cefaclor in outpatient management of community-acquired lower respiratory tract infections.

July 1989, Journal of chemotherapy (Florence, Italy),

R Pariente, and J Rochemaure, and D Murciano, and J M Brechot, and M Pappo

Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections.

February 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

R Pariente, and J Rochemaure, and D Murciano, and J M Brechot, and M Pappo

[Cefuroxime axetil in the treatment of lower respiratory tract infections in patients with chronic lung diseases].

May 1992, Anales de medicina interna (Madrid, Spain : 1984),

R Pariente, and J Rochemaure, and D Murciano, and J M Brechot, and M Pappo

Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.

August 1989, Antimicrobial agents and chemotherapy,

R Pariente, and J Rochemaure, and D Murciano, and J M Brechot, and M Pappo

Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.

January 1987, Drugs under experimental and clinical research,

R Pariente, and J Rochemaure, and D Murciano, and J M Brechot, and M Pappo

A dose-ranging study of cefuroxime axetil in the treatment of lower respiratory tract infections in general practice.

January 1987, Drugs under experimental and clinical research,